Get the Stockscreener App
6.36
100.00%
3.18
Pre-market:
5.25
-1.11
-17.45%
Virax Biolabs Group Ltd stock is traded at $6.36, with a volume of 71.43M.
It is up +100.00% in the last 24 hours and up +35.18% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.
See More
Previous Close:
$3.18
Open:
$11.09
24h Volume:
71.43M
Relative Volume:
33.84
Market Cap:
$5.07M
Revenue:
$3,000
Net Income/Loss:
$-5.65M
P/E Ratio:
-5.0795
EPS:
-1.2521
Net Cash Flow:
$-5.88M
1W Performance:
+103.19%
1M Performance:
+35.18%
6M Performance:
-29.72%
1Y Performance:
-72.46%
1-Day Range:
$5.8632
$13.19
1-Week Range:
$2.84
$13.19
52-Week Range:
$2.50
$28.50
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
6.36 | 5.07M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
496.50 | 126.01B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.95 | 70.03B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
909.49 | 56.56B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.79 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.13 | 40.63B | 742.00K | -1.37B | -1.07B | -7.0731 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Thursday's after hours session: top gainers and losers - ChartMill
Virax Biolabs secures $3.3m from warrant exercise By Investing.com - Investing.com South Africa
Thursday's session: most active stocks - ChartMill
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Virax Biolabs signs supply deal with Fosun Diagnostics By Investing.com - Investing.com India
Gold Gains Over 1%; PepsiCo Shares Fall After Q2 Results - Benzinga
Virax Biolabs Jumps on Fosun Diagnostics Supply Agreement - Quiver Quantitative
Virax Biolabs (VRAX) Stock Explodes 241% on Fosun Diagnostics Partnership - parameter.io
Virax Biolabs (VRAX) Stock Rockets 241% on Fosun Diagnostics Partnership - Blockonomi
Why Did Virax Biolabs Stock Triple In One Session? - Benzinga
Virax Biolabs (VRAX) Stock Surges 241% After Exclusive Southeast Asia Supply Deal - CoinCentral
Forte Biosciences Shares Climb After Positive Phase 1b Vitiligo Trial Results (FBRX) - Yahoo Finance
Trending Stocks Today | Virax Biolabs Soars 259.74% - Moomoo
Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX) - Yahoo Finance
Nasdaq Gains 100 Points; US Initial Jobless Claims Edge Lower - Benzinga
Virax Biolabs signs multi-country commercial agreement with Fosun Diagnostics - TipRanks
Morning Market Movers: VRAX, AFJK, SDOT, IONS See Big Swings - RTTNews
Discover the top movers in Thursday's pre-market session. - ChartMill
Virax Biolabs Strikes Exclusive Southeast Asia Supply Deal for ImmuneSelect with Fosun Diagnostics - TipRanks
Virax Biolabs stock surges 100% on Fosun supply deal By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Virax Biolabs (NASDAQ: VRAX) inks multi-country ImmuneSelect supply deal - Stock Titan
Virax Biolabs signs supply pact for six Southeast Asian markets - Stock Titan
Virax Biolabs | 20-F: Registration statement / Annual report / Transition report - Moomoo
Virax Biolabs Company Profile & Introduction - Moomoo
Virax Biolabs : Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F) - marketscreener.com
[20-F] Virax Biolabs Group Ltd Files Annual Report (Foreign Issuer) | VRAX SEC FilingForm 20-F - Stock Titan
Virax Biolabs Approves 1-for-25 Share Consolidation to Maintain Nasdaq Listing - The Globe and Mail
Virax Biolabs (NASDAQ: VRAX) enacts 1-for-25 share consolidation to meet Nasdaq bid rule - Stock Titan
Virax Biolabs (VRAX) Implements 1-for-25 Share Consolidation to Sustain Nasdaq Listing - GuruFocus
Virax Biolabs announces 1-for-25 reverse stock split - Investing.com
Virax Biolabs announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
Virax Biolabs cuts shares 25-to-1 to try to keep Nasdaq listing - Stock Titan
Virax Biolabs Group Ltd (VRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Virax Biolabs Group Ltd (VRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Virax Biolabs Group Ltd (VRAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Virax Biolabs Group Ltd (VRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Virax Biolabs Group Ltd (VRAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Virax Biolabs Group Ltd (VRAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Institutional Confidence - TradingKey
Virax Biolabs Group Ltd (VRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
These stocks are moving in today's after hours session - ChartMill
Virax Biolabs Shareholders Approve Reverse Split and Amended Charter at June 12 Meeting - TipRanks
Virax Biolabs (VRAX) investors approve reverse split range and new charter - Stock Titan
What's going on in today's after hours session - ChartMill
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch - marketscreener.com
Virax Biolabs (VRAX) Shows Promising Data for Long COVID Test - GuruFocus
Virax Biolabs reports positive pilot data for long COVID blood test - grafa.com
Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study - TipRanks
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):